MJ Biotech, Inc Financial Corporate Update
CHEYENNE, Wyo., March 08, 2018 (GLOBE NEWSWIRE) -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) Zen’s Tea House, sales results for February 2018 were just over $138,000; combining that with the January 2018 sales of over $120,000, these sales result in an income stream of over $250,000 for 2 months.
Zen Hero, Inc. DBA Zen’s Tea House, founded in 2012, is a Southern California based manufacturing-retailer that specializes in Loose Leaf Botanical Nutraceuticals. Zen's Tea House works with licensed nutritionists, naturopathic doctors, and holistic medical practitioners creating beneficial herbal remedies. Many people use these blends as an organic alternative. The rising demand for these Nutraceuticals has created a robust growth in multi-channel retail outlets, establishing Zen's Tea House as a leading tea and herb retailer in Southern California. Zen's Tea House creates proprietary blends for Doctors and their patients, while maintaining a wide assortment of Teas and Herbs available for public consumption.
Zen’s Tea House operates in Farmers Markets, and Private Events. Zen’s founder Fernando Lopez is well respected in the holistic nutraceutical industry, and is the primary developer of Zen’s proprietary blends of Teas and Herbs. Zen currently operates in over 48 Farmers Markets and expects to increase its distribution with an additional 20 markets over the next 12 months.
Meet Fernando Lopez the COO of MJ Biotech and President of Zen Tea House. via Facebook at https://www.facebook.com/zensteahouse.
MJ Biotech will be holding an Investor Conference Call March 21, 2018 at 10:00 AM (PST) and requests shareholders and potential investors to send questions to email@example.com ; all questions selected for the Investor Conference Call will be posed to MJ Biotech management and the Inquirers will receive a Free Sample of Golden Milk, which is Zen’s Top selling proprietary blend.
Safe Harbor Statement
This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as "would," "may," "will," "expects," and other terms with similar meaning. Forward-looking statements are based on current beliefs, assumptions and expectations and speak only as of the date of this release and involve risks and uncertainties that could cause actual results to differ materially from current expectations. We assume no obligation to update or revise any forward-looking statement, whether because of new information, future events or any other reason.
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Upcoming Life Sciences Events
- March 2019
- Vienna: RESI Vienna 2019
- Vienna: BIO-Europe Spring 2019
- April 2019
- Zurich: The Pharma Business Development Course